Effect of Repeat Administration of Eslicarbazepine Acetate on the Pharmacokinetics of a Combined Oral Contraceptive

Clinical trial NCT00898560 · COMPLETED

Trial details

NCT number: NCT00898560
Sponsor: Bial - Portela C S.A.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Partial Epilepsy

Start date: 2008-09-01
Primary completion: 2008-11-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.